NASDAQ · Biotechnology

RPRX (RPRX) Stock

$63.88 +1.22% NASDAQ: RPRX Healthcare

Valuation

MetricValue
Price$63.88
Market Cap$28.32B
P/E Ratio25.25
P/B Ratio3.96
P/S Ratio10.64
EPS (TTM)$1.80
52-Week High$63.88
52-Week Low$34.08
Dividend Yield1.54%

Financials & Margins

MetricValue
ROE12.25%
ROA4.11%
ROCE8.24%
Gross Margin1.15%
Operating Margin1.00%
Net Margin32.15%
Debt/Equity1.31
Current Ratio2.66

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.3B$2.2B$2.4B$2.3B$2.4B
Operating Profit$1.4B$307.0M$1.5B$1.3B$1.6B
Net Profit$620.0M$43.0M$1.1B$859.0M$771.0M
EPS$1.49$0.10$2.53$1.91$1.80
Op Margin62.5%13.7%63.4%57.1%65.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$17.5B$16.8B$16.4B$18.2B$19.6B
Total Liabilities$7.3B$7.3B$6.3B$7.9B$9.9B
Cash$1.5B$1.7B$477.0M$929.0M$619.0M
Borrowings$7.1B$7.1B$6.1B$7.6B$9.0B

Latest News

Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026 GlobeNewswire · Jul 15, 2026 Why Royalty Pharma (RPRX) Could Beat Earnings Estimates Again Zacks · Jul 10, 2026 Are You Looking for a Top Momentum Pick? Why Royalty Pharma (RPRX) is a Great Choice Zacks · Jul 10, 2026 Royalty Pharma PLC (RPRX) Hits Fresh High: Is There Still Room to Run? Zacks · Jul 10, 2026 RPRX or ACAD: Which Is the Better Value Stock Right Now? Zacks · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$2.0B$2.1B$3.0B$2.8B$2.5B
Investing Cash Flow$-1.9B$-1.0B$-2.1B$-2.7B$-1.6B
Financing Cash Flow$-602.0M$-612.0M$-790.0M$-734.0M$-1.8B
Net Cash Flow$532.0M$170.0M$-1.2B$452.0M$-310.0M
Free Cash Flow$2.0B$2.1B$3.0B$2.8B$2.5B

Valuation & Return Ratios

MetricValue
PEG Ratio7.35
EV / EBITDA20.47
FCF Yield11.03%
Quick Ratio1.29
Interest Coverage4.38
Return 1Y76.57%
Return 3Y122.26%
Return 5Y77.24%

Ownership

Insiders Held6.51%
Institutions Held86.04%
Institutions Float Held92.04%
Institutional HolderSharesReport Date
Morgan Stanley43,571,6332026-03-31
Capital International Investors35,005,7362026-03-31
Blackrock Inc.25,907,7452026-03-31
FMR, LLC25,152,2422026-03-31
BAILLIE GIFFORD & CO16,155,6772026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
EXEL $59.13 +1.03% 16.55 $14.86B 0.00%
FMSFresenius Medical Care AG & Co. KGaA $23.69 -1.86% 12.64 $12.72B 3.63%
GMABGenmab A/S $29.00 -2.62% 21.45 $17.80B 0.00%
HOLXHologic, Inc. $76.01 +0.00% 31.28 $16.97B 0.00%
INCY $128.00 -0.64% 15.30 $25.95B 0.00%

About RPRX

RPRX is led by CEO Pablo Legorreta, employs 75 people, headquartered in New York, US, publicly traded since 2020.

RPRX stock trades at $63.88 with a market capitalization of $28.32B. The stock is valued at a price-to-earnings (P/E) ratio of 25.25, price-to-book of 3.96, price-to-sales of 10.64. Over the past 52 weeks the stock has ranged between $34.08 and $63.88, and currently trades at its 52-week high. It pays a dividend yielding 1.54%.

On profitability, RPRX generates a return on equity (ROE) of 12.25%, above the typical market average, return on capital employed of 8.24%, an operating margin of 1.00%, a net profit margin of 32.15%.

In its most recent fiscal year, RPRX reported annual revenue of $2.4B, net profit of $771.0M, revenue has compounded at 2.3% a year over the last five years, profit at -4.6% a year.

The balance sheet shows a debt-to-equity ratio of 1.31, a current ratio of 2.66, total assets of $19.6B, $619.0M in cash and equivalents.

RPRX has a beta of 0.42 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.50 -0.05% JNJ Drug Manufacturers - General $278.43 +1.17% ABBV Drug Manufacturers - General $260.30 -0.54% MRK Drug Manufacturers - General $152.34 +0.46% UNH Medical - Healthcare Plans $400.94 +0.32% NVS Drug Manufacturers - General $163.09 +0.39% AZN Drug Manufacturers - General $164.77 +1.94% AMGN Drug Manufacturers - General $444.12 +0.29% TMO Medical - Diagnostics & Research $618.43 +1.63% NVO Biotechnology $47.51 +1.58% ABT Medical - Devices $108.80 -1.51% GILD Drug Manufacturers - General $151.22 +1.08%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides